USCWA
ZOM

U.S. Capital Wealth Advisors’s Zomedica Corp. ZOM Stock Holding History

U.S. Capital Wealth Advisors’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,055
Closed -$987 – 1621
2022
Q4 		$987 Buy
+6,055
New +$1.24K ﹤0.01% 1533

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PWMG
Pinnacle Wealth Management Group Plymouth, Michigan $214M AUM 20.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

U.S. Capital Wealth Advisors's ZOM Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Zomedica Corp. (ZOM) in Q1 2023, closing a stake of 6,055 shares — an estimated $987 sold.

U.S. Capital Wealth Advisors first reported a position in ZOM in Q4 2022 and held it in 1 quarter. The position peaked at $987 in Q4 2022. 90 funds tracked by Wall St. Rank hold ZOM as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Zomedica Corp. position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 6,055 Zomedica Corp. shares in Q1 2023, an estimated $987.
  • U.S. Capital Wealth Advisors first reported a position in Zomedica Corp. in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Zomedica Corp. position peaked at $987 in Q4 2022.
  • 90 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.